Jupiter Neurosciences, Inc.
JUNS
$1.21
$0.032.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 7.55% | 62.72% | |||
| Gross Profit | -7.55% | -62.72% | |||
| SG&A Expenses | -1.66% | 40.52% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.42% | 47.26% | |||
| Operating Income | -1.42% | -47.26% | |||
| Income Before Tax | -1.55% | -47.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.55% | -47.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.55% | -47.36% | |||
| EBIT | -1.42% | -47.26% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 1.03% | -46.97% | |||
| Normalized Basic EPS | 0.94% | -46.71% | |||
| EPS Diluted | 4.00% | -51.52% | |||
| Normalized Diluted EPS | 0.94% | -46.71% | |||
| Average Basic Shares Outstanding | 2.59% | 0.23% | |||
| Average Diluted Shares Outstanding | 2.59% | 0.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||